Biopharmaceutical Third-Party Logistics Market Size, Trends, Analysis, and Outlook By Supply Chain, Cold Chain, Non-cold Chain), By Service (Transportation, Warehousing & Storage, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Biopharmaceutical Third-Party Logistics market size is poised to register 7.38% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biopharmaceutical Third-Party Logistics market across By Supply Chain, Cold Chain, Non-cold Chain), By Service (Transportation, Warehousing & Storage, Others).
The biopharmaceutical third-party logistics (3PL) market is poised for significant growth, driven by various factors in 2024 and beyond. Biopharmaceutical companies rely on 3PL providers to manage and optimize their supply chain operations, including warehousing, transportation, distribution, and logistics management, ensuring the timely and efficient delivery of biologic products to patients, healthcare providers, and distribution centers. Market growth is fueled by the increasing complexity of the biopharmaceutical supply chain, driven by factors such as globalization, temperature-sensitive products, and regulatory requirements, driving the need for specialized logistics solutions. Moreover, the expanding portfolio of biopharmaceutical products, including biologics, vaccines, and cell therapies, is driving demand for cold chain logistics services to maintain product integrity and stability during transportation and storage. Additionally, the growing emphasis on patient-centric healthcare models and direct-to-patient distribution channels is driving the adoption of innovative logistics solutions tailored to the unique requirements of biopharmaceutical products, further propelling market expansion. Furthermore, strategic collaborations and partnerships between biopharmaceutical companies and 3PL providers are driving innovation, technology adoption, and market competitiveness, shaping industry dynamics.
Biopharmaceutical Third-Party Logistics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biopharmaceutical Third-Party Logistics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biopharmaceutical Third-Party Logistics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biopharmaceutical Third-Party Logistics industry.
Key market trends defining the global Biopharmaceutical Third-Party Logistics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biopharmaceutical Third-Party Logistics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biopharmaceutical Third-Party Logistics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biopharmaceutical Third-Party Logistics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biopharmaceutical Third-Party Logistics industry
Leading Biopharmaceutical Third-Party Logistics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biopharmaceutical Third-Party Logistics companies.
Biopharmaceutical Third-Party Logistics Market Study- Strategic Analysis Review
The Biopharmaceutical Third-Party Logistics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Biopharmaceutical Third-Party Logistics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biopharmaceutical Third-Party Logistics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biopharmaceutical Third-Party Logistics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biopharmaceutical Third-Party Logistics market segments. Similarly, Strong end-user demand is encouraging Canadian Biopharmaceutical Third-Party Logistics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biopharmaceutical Third-Party Logistics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biopharmaceutical Third-Party Logistics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biopharmaceutical Third-Party Logistics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biopharmaceutical Third-Party Logistics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biopharmaceutical Third-Party Logistics in Asia Pacific. In particular, China, India, and South East Asian Biopharmaceutical Third-Party Logistics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biopharmaceutical Third-Party Logistics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biopharmaceutical Third-Party Logistics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biopharmaceutical Third-Party Logistics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biopharmaceutical Third-Party Logistics.
Biopharmaceutical Third-Party Logistics Market Company Profiles
The global Biopharmaceutical Third-Party Logistics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agility, AmerisourceBergen Corp, DB Schenker, DHL International GmbH, Kerry Logistics Network Ltd, Kuehne and Nagel, SF Express, United Parcel Service of America Inc
Recent Biopharmaceutical Third-Party Logistics Market Developments
The global Biopharmaceutical Third-Party Logistics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biopharmaceutical Third-Party Logistics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Supply Chain
Cold Chain
Non-cold Chain
By Service Type
Transportation
-Air Freight
-Sea Freight
-Overland
Warehousing & Storage
Others
Geographical Segmentation:
Agility
AmerisourceBergen Corp
DB Schenker
DHL International GmbH
Kerry Logistics Network Ltd
Kuehne and Nagel
SF Express
United Parcel Service of America Inc
Formats Available: Excel, PDF, and PPT
The biopharmaceutical third-party logistics (3PL) market is poised for significant growth, driven by various factors in 2024 and beyond. Biopharmaceutical companies rely on 3PL providers to manage and optimize their supply chain operations, including warehousing, transportation, distribution, and logistics management, ensuring the timely and efficient delivery of biologic products to patients, healthcare providers, and distribution centers. Market growth is fueled by the increasing complexity of the biopharmaceutical supply chain, driven by factors such as globalization, temperature-sensitive products, and regulatory requirements, driving the need for specialized logistics solutions. Moreover, the expanding portfolio of biopharmaceutical products, including biologics, vaccines, and cell therapies, is driving demand for cold chain logistics services to maintain product integrity and stability during transportation and storage. Additionally, the growing emphasis on patient-centric healthcare models and direct-to-patient distribution channels is driving the adoption of innovative logistics solutions tailored to the unique requirements of biopharmaceutical products, further propelling market expansion. Furthermore, strategic collaborations and partnerships between biopharmaceutical companies and 3PL providers are driving innovation, technology adoption, and market competitiveness, shaping industry dynamics.
Biopharmaceutical Third-Party Logistics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biopharmaceutical Third-Party Logistics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biopharmaceutical Third-Party Logistics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biopharmaceutical Third-Party Logistics industry.
Key market trends defining the global Biopharmaceutical Third-Party Logistics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biopharmaceutical Third-Party Logistics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biopharmaceutical Third-Party Logistics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biopharmaceutical Third-Party Logistics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biopharmaceutical Third-Party Logistics industry
Leading Biopharmaceutical Third-Party Logistics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biopharmaceutical Third-Party Logistics companies.
Biopharmaceutical Third-Party Logistics Market Study- Strategic Analysis Review
The Biopharmaceutical Third-Party Logistics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Biopharmaceutical Third-Party Logistics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biopharmaceutical Third-Party Logistics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biopharmaceutical Third-Party Logistics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biopharmaceutical Third-Party Logistics market segments. Similarly, Strong end-user demand is encouraging Canadian Biopharmaceutical Third-Party Logistics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biopharmaceutical Third-Party Logistics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biopharmaceutical Third-Party Logistics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biopharmaceutical Third-Party Logistics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biopharmaceutical Third-Party Logistics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biopharmaceutical Third-Party Logistics in Asia Pacific. In particular, China, India, and South East Asian Biopharmaceutical Third-Party Logistics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biopharmaceutical Third-Party Logistics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biopharmaceutical Third-Party Logistics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biopharmaceutical Third-Party Logistics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biopharmaceutical Third-Party Logistics.
Biopharmaceutical Third-Party Logistics Market Company Profiles
The global Biopharmaceutical Third-Party Logistics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agility, AmerisourceBergen Corp, DB Schenker, DHL International GmbH, Kerry Logistics Network Ltd, Kuehne and Nagel, SF Express, United Parcel Service of America Inc
Recent Biopharmaceutical Third-Party Logistics Market Developments
The global Biopharmaceutical Third-Party Logistics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biopharmaceutical Third-Party Logistics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Supply Chain
Cold Chain
Non-cold Chain
By Service Type
Transportation
-Air Freight
-Sea Freight
-Overland
Warehousing & Storage
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agility
AmerisourceBergen Corp
DB Schenker
DHL International GmbH
Kerry Logistics Network Ltd
Kuehne and Nagel
SF Express
United Parcel Service of America Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Biopharmaceutical Third-Party Logistics Market Overview and Key Findings, 2024
1.2 Biopharmaceutical Third-Party Logistics Market Size and Growth Outlook, 2021- 2030
1.3 Biopharmaceutical Third-Party Logistics Market Growth Opportunities to 2030
1.4 Key Biopharmaceutical Third-Party Logistics Market Trends and Challenges
1.4.1 Biopharmaceutical Third-Party Logistics Market Drivers and Trends
1.4.2 Biopharmaceutical Third-Party Logistics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biopharmaceutical Third-Party Logistics Companies
2. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET SIZE OUTLOOK TO 2030
2.1 Biopharmaceutical Third-Party Logistics Market Size Outlook, USD Million, 2021- 2030
2.2 Biopharmaceutical Third-Party Logistics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Supply Chain
Cold Chain
Non-cold Chain
By Service Type
Transportation
-Air Freight
-Sea Freight
-Overland
Warehousing & Storage
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biopharmaceutical Third-Party Logistics Market, 2025
5.2 Asia Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biopharmaceutical Third-Party Logistics Market, 2025
5.5 Europe Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.6 Europe Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biopharmaceutical Third-Party Logistics Market, 2025
5.8 North America Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.9 North America Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biopharmaceutical Third-Party Logistics Market, 2025
5.11 South America Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.12 South America Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biopharmaceutical Third-Party Logistics Market, 2025
5.14 Middle East Africa Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biopharmaceutical Third-Party Logistics Market Size Outlook and Revenue Growth Forecasts
6.2 US Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
7. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS COMPANY PROFILES
8.1 Profiles of Leading Biopharmaceutical Third-Party Logistics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agility
AmerisourceBergen Corp
DB Schenker
DHL International GmbH
Kerry Logistics Network Ltd
Kuehne and Nagel
SF Express
United Parcel Service of America Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Biopharmaceutical Third-Party Logistics Market Overview and Key Findings, 2024
1.2 Biopharmaceutical Third-Party Logistics Market Size and Growth Outlook, 2021- 2030
1.3 Biopharmaceutical Third-Party Logistics Market Growth Opportunities to 2030
1.4 Key Biopharmaceutical Third-Party Logistics Market Trends and Challenges
1.4.1 Biopharmaceutical Third-Party Logistics Market Drivers and Trends
1.4.2 Biopharmaceutical Third-Party Logistics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biopharmaceutical Third-Party Logistics Companies
2. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET SIZE OUTLOOK TO 2030
2.1 Biopharmaceutical Third-Party Logistics Market Size Outlook, USD Million, 2021- 2030
2.2 Biopharmaceutical Third-Party Logistics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Supply Chain
Cold Chain
Non-cold Chain
By Service Type
Transportation
-Air Freight
-Sea Freight
-Overland
Warehousing & Storage
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biopharmaceutical Third-Party Logistics Market, 2025
5.2 Asia Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biopharmaceutical Third-Party Logistics Market, 2025
5.5 Europe Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.6 Europe Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biopharmaceutical Third-Party Logistics Market, 2025
5.8 North America Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.9 North America Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biopharmaceutical Third-Party Logistics Market, 2025
5.11 South America Pacific Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.12 South America Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biopharmaceutical Third-Party Logistics Market, 2025
5.14 Middle East Africa Biopharmaceutical Third-Party Logistics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biopharmaceutical Third-Party Logistics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biopharmaceutical Third-Party Logistics Market Size Outlook and Revenue Growth Forecasts
6.2 US Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biopharmaceutical Third-Party Logistics Industry Drivers and Opportunities
7. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOPHARMACEUTICAL THIRD-PARTY LOGISTICS COMPANY PROFILES
8.1 Profiles of Leading Biopharmaceutical Third-Party Logistics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agility
AmerisourceBergen Corp
DB Schenker
DHL International GmbH
Kerry Logistics Network Ltd
Kuehne and Nagel
SF Express
United Parcel Service of America Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
